Detailed answers about NORTH BRITISH RHEUMATOLOGY PRACTICE LIMITED, including incorporation, status, business activity, and accounts information.
When was NORTH BRITISH RHEUMATOLOGY PRACTICE LIMITED founded?
NORTH BRITISH RHEUMATOLOGY PRACTICE LIMITED was officially incorporated on 5 June 2015 and is registered under company number 09625249. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is NORTH BRITISH RHEUMATOLOGY PRACTICE LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of NORTH BRITISH RHEUMATOLOGY PRACTICE LIMITED?
NORTH BRITISH RHEUMATOLOGY PRACTICE LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does NORTH BRITISH RHEUMATOLOGY PRACTICE LIMITED do?
NORTH BRITISH RHEUMATOLOGY PRACTICE LIMITED operates in the following sector: 86220 - Specialists medical practice activities. This provides insight into the company's primary business activity and industry focus.
What is NORTH BRITISH RHEUMATOLOGY PRACTICE LIMITED's registered address?
The registered office address of NORTH BRITISH RHEUMATOLOGY PRACTICE LIMITED is C/O SANDISON EASSON & CO REX BUILDINGS, ALDERLEY ROAD, WILMSLOW, CHESHIRE, UNITED KINGDOM, SK9 1HY. This is the official address filed with Companies House for legal and statutory correspondence.
Is NORTH BRITISH RHEUMATOLOGY PRACTICE LIMITED financially stable?
The most recent accounts for NORTH BRITISH RHEUMATOLOGY PRACTICE LIMITED were made up to 31 March 2025, filed as MICRO ENTITY. Next accounts are due by 30 December 2026.